Dr. Maluccio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4204 Houma Blvd
Metairie, LA 70006Phone+1 504-503-5426Fax+1 504-568-2726
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1994 - 2002
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1994, MD. MPH, AOA
Certifications & Licensure
- GA State Medical License 2022 - 2025
- IN State Medical License 2004 - 2025
- LA State Medical License 2019 - 2025
- MS State Medical License 2022 - 2025
- OK State Medical License 2020 - 2025
- TX State Medical License 2023 - 2025
- AL State Medical License 2020 - 2024
- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- Indianapolis Monthly Top Doctor Castle Connolly, 2013-2014
- Best Doctor Best Doctor, 2013-2014
- Fellow American College of Surgeons
Clinical Trials
- Storage of Bile From Routine Procedures to Study Risk Factors Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- 886 citationsCyclosporine induces cancer progression by a cell-autonomous mechanismMinoru Hojo, Takashi Morimoto, Mary A. Maluccio, Tomohiko Asano, Kengo Morimoto
Nature. 1999-02-11 - 697 citationsRecent progress in understanding, diagnosing, and treating hepatocellular carcinoma.Mph Mary Maluccio Md, Anne M. Covey
CA. 2012-11-01 - 193 citationsRapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.Fu L. Luan, Minoru Hojo, Mary A. Maluccio, Kouzaburo Yamaji, Manikkam Suthanthiran
Transplantation. 2002-05-27
Grant Support
- Metabolomics-Based Identification Of Hepatocellular Cancer BiomarkersNational Cancer Institute2009–2010
- The Renin-Angiotensin System In Hepatitis And HepatomaNational Cancer Institute2007–2008
- The Regin-Angiotensin System In Hepatitis And HepatomaNational Cancer Institute2006
- Optimizing Immunotherapy Of Renal Cell CancerNational Cancer Institute1998–1999
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: